value award of MedTech
CardiaCare has been selected as one of the top five companies in the value award of MedTech Innovator 2022 cohort
© 2022 CardiaCare. All right reserved. | Ux & Ui By Studiomelamed.com
CardiaCare has been selected as one of the top five companies in the value award of MedTech Innovator 2022 cohort
CardiaCare has been selected to take part in MedTech Innovator program. Selected as one of top 50 Startups out of 1000 applicants for the 2022 Cohort in the Tenth Year of World’s Largest MedTech Accelerator Program
CardiaCare successfully completed it’s First in Human Clinical trial in Atrial Fibrillation (AF) patients arriving to the emergency room of the Chaim Sheba Medical Center. Patients have received the CardiaCare RR2 device for 8 weeks of home-care neuromodulation therapy and monitoring. The results demonstrated a high device safety profile, a significant acute reduction in AF precursor arrythmia events as well as long term reduction in AF recurrence rates after discharge from the hospital. In this real-life population study the home-care compliance with with device monitoring and therapeutic capabilities was extremely high.
TEL AVIV, Israel, Dec. 16, 2019 /PRNewswire/ — CardiaCare, a startup developing wearable therapeutic devices for treating and monitoring AFib, announced today that it has been named the First Prize winner of the 2019 Innovation in Cardiovascular Interventions (ICI) Technology Parade in Tel Aviv. CardiaCare presented its innovative product, a wearable neuromodulation (nerve stimulation) device for monitoring and treating AFIb. Read More.
CardiaCare to participate in MedTech Innovator Neuromodulation Therapies Showcase at AdvaMed MedTech Conference in Boston, October 2022
CardiaCare will present at the Wilson Sonsini Goodrich & Rosati’s 29th Annual Medical Device Conference 2022
Dr. Avi Sabag from Sheba Medical Center Cardiology presented the trial’s results at two prestigious conferences: The IDSS 2022 and the AF Symposium 2022
Prof. Vivek from Mount Sinai Cardiology Presents CardiaCare at the Prestigious Atrial Fibrillation Symposium 2021
CardiaCare receives IRB and MOH approval to commence it’s first in human atrial fibrillation study in Sheba Medical Center Israel
CardiaCare presents progress at ICI2021 online Innovations in Cardiovascular Interventions Meeting
CardiaCare closed loop technology presenting at the American Diabetes Association Leaders Forum
CardiaCare presenting it’s technology in prestigious Rambam Foundation Cardiology meeting in New York.
CardiaCare presenting at Wearable Tech Digital Health Neurotech Silicon Valley Summit.
CardiaCare presenting at 16th International Dead Sea Symposium on Innovations in Cardiac Arrhythmias and Heart Failure (IDSS) 2020.
CardiaCare presented it’s technology at prestige China-Israel conference of Health Tech innovation
CardiaCare Awarded First Prize Winner of the Technology Parade Startup Competition in ICI2019 Meeting
© 2022 CardiaCare. All right reserved. | Ux & Ui By Studiomelamed.com